Exploratory study shows melatonin improves sleep and reduces enuresis in children, indicating potential benefits for treatment-resistant cases.
This exploratory study evaluated the use of melatonin to treat patients with nocturnal enuresis. Patients were seen at a tertiary paediatric outpatient clinic between February 2012 and March 2014. Data summarises results in children with nocturnal enuresis who returned for follow-up after being prescribed melatonin. Data collected from the medical records included: demographics, medical and sleep history, incontinence, any previous treatments and response to melatonin. Factors associated with treatment response are presented using descriptive statistics. A total of 39 children diagnosed with nocturnal enuresis were prescribed melatonin. Seven had no follow-up data so data for 32 patients are included. Most participants (94%) had not responded to prior treatment and had non-monosymptomatic enuresis (84%). Sleep problems were reported in all. After melatonin, 90.6% (29/32) reported sleeping better and 75% (24/32) became dry. In addition, 81.3% (26/32) now reporting waking to void, included: 80% (16/20) who used melatonin in conjunction with alarm training and 83.3% (10 of 12) who used melatonin without alarm therapy. Responders included 81.5% (22/27) who had previously failed alarm training and 95.5% (21/22) who previously failed desmopressin. This report of melatonin effectiveness as an adjunct for treating enuresis, suggests a need for additional studies to further define its role in the management of treatmentresistant enuresis.
No takes yet. Share an insight, caveat, or question.
Waters et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: